25th Jul 2014 09:59
25 July 2014
| AIM: RENE |
ReNeuron Group plc
("ReNeuron" or the "Company")
Director/PDMR Shareholding
The Board of ReNeuron Group plc (AIM: RENE.L) has been informed that Michael Hunt, Chief Executive Officer and John Sinden, Chief Scientific Officer of the Company have today each purchased 93,892 ordinary shares of 1 pence ("Ordinary Shares") at a price of 3.5 pence per share.
Following this transaction, Mr Hunt is interested in a total of 1,346,915 Ordinary Shares in the Company, representing approximately 0.08% of the total issued share capital. Mr Sinden is interested in a total of 2,305,794 Ordinary Shares in the Company, representing approximately 0.13% of the total issued share capital.
Enquiries:
ReNeuron | +44 (0) 1483 302560 |
Michael Hunt, Chief Executive Officer | |
Dr John Sinden, Chief Scientific Officer | |
Buchanan | +44 (0) 20 7466 5000 |
Mark Court, Fiona Henson, Sophie Cowles | |
Cenkos Securities | +44 (0) 20 7397 8900 |
Stephen Keys, Dr Christopher Golden (NOMAD and Broker) | |
Andy Roberts (Sales) |
Related Shares:
RENE.L